179 related articles for article (PubMed ID: 9155672)
1. Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.
Ilyas M; Novelli M; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Talbot IC
J Clin Pathol; 1997 Mar; 50(3):218-22. PubMed ID: 9155672
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
3. Jass staging is a predictor of outcome following "curative" resection of Dukes' B colorectal carcinoma.
Mander BJ; Carney LJ; Scott HJ; Donaldson DR
Surgeon; 2006 Aug; 4(4):227-30. PubMed ID: 16892840
[TBL] [Abstract][Full Text] [Related]
4. A Dukes/Jass combination--is it more discriminating?
Haslam AC; Pearson JM; Bisset DL; Michie HR; Hobbiss JH
Colorectal Dis; 2006 Jun; 8(5):418-22. PubMed ID: 16684086
[TBL] [Abstract][Full Text] [Related]
5. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
7. Jass' classification revisited.
Deans GT; Heatley M; Anderson N; Patterson CC; Rowlands BJ; Parks TG; Spence RA
J Am Coll Surg; 1994 Jul; 179(1):11-7. PubMed ID: 8019715
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.
Sheehan KM; O'Donovan DG; Fitzmaurice G; O'Grady A; O'Donoghue DP; Sheahan K; Byrne MF; Conroy RM; Kay EW; Murray FE
Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):375-80. PubMed ID: 12655257
[TBL] [Abstract][Full Text] [Related]
9. Cadherin-catenin expression in primary colorectal cancer: a survival analysis.
Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR
Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114
[TBL] [Abstract][Full Text] [Related]
10. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
11. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
12. Relationship between degree of cellular differentiation in colorectal cancer and topographical distribution.
Linares Santiago E; Sánchez Calzado JA; Capitán Morales L; Gómez Parra M; González Mariscal MJ; Mendoza Olivares FJ; Sáenz Dana M; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2002 Feb; 94(2):78-87. PubMed ID: 12185656
[TBL] [Abstract][Full Text] [Related]
13. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
14. Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).
Fisher ER; Robinsky B; Sass R; Fisher B
Dis Colon Rectum; 1989 Nov; 32(11):944-9. PubMed ID: 2478350
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor messenger RNA in human colorectal carcinomas assessed by non-radioactive in-situ hybridization.
Komuta K; Koji T; Izumi S; Matsumoto T; Kohara N; Motojima K; Kanematsu T; Nakane PK
Eur J Surg Oncol; 1995 Jun; 21(3):269-75. PubMed ID: 7781795
[TBL] [Abstract][Full Text] [Related]
16. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer.
Neoptolemos JP; Oates GD; Newbold KM; Robson AM; McConkey C; Powell J
Br J Surg; 1995 Feb; 82(2):184-7. PubMed ID: 7749683
[TBL] [Abstract][Full Text] [Related]
17. The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival.
Murphy J; O'Sullivan GC; Lee G; Madden M; Shanahan F; Collins JK; Talbot IC
Am J Gastroenterol; 2000 Dec; 95(12):3607-14. PubMed ID: 11151900
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
19. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.
Ilyas M; Hao XP; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Bodmer WF; Talbot IC
Gut; 1998 Sep; 43(3):383-7. PubMed ID: 9863484
[TBL] [Abstract][Full Text] [Related]
20. Investigation of β-catenin and E-cadherin expression in Dukes B2 stage colorectal cancer with tissue microarray method. Is it a marker of metastatic potential in rectal cancer?
Tóth L; András C; Molnár C; Tanyi M; Csiki Z; Molnár P; Szántó J
Pathol Oncol Res; 2012 Apr; 18(2):429-37. PubMed ID: 21975680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
